Detalles de la búsqueda
1.
Placebo response in patients with Dravet syndrome: Post-hoc analysis of two clinical trials.
Epilepsy Behav
; 156: 109805, 2024 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38677101
2.
Dravet syndrome seizure frequency and clustering: Placebo-treated patients in clinical trials.
Epilepsy Behav
; 155: 109774, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38643658
3.
Seizure-free days as a novel outcome in patients with Lennox-Gastaut syndrome: Post hoc analysis of patients receiving cannabidiol in two randomized controlled trials.
Epilepsia
; 64(7): 1812-1820, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37052803
4.
Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials.
Acta Neurol Scand
; 143(2): 154-163, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32969022
5.
Retrospective chart review study of use of cannabidiol (CBD) independent of concomitant clobazam use in patients with Lennox-Gastaut syndrome or Dravet syndrome.
Seizure
; 110: 78-85, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37331197
6.
Treatment Guidelines for Rare, Early-Onset, Treatment-Resistant Epileptic Conditions: A Literature Review on Dravet Syndrome, Lennox-Gastaut Syndrome and CDKL5 Deficiency Disorder.
Front Neurol
; 12: 734612, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34759881
Resultados
1 -
6
de 6
1
Próxima >
>>